Table 1.

Patients demographics at baseline

	Patient 1	Patient 2	Patient 3
Gender	female	male	male
Age in years	17	9	17
Localisation of uveitis	intermediate	intermediate	intermediate
Study eye	LE	LE	RE
Indication, symptoms	CME	VH	CME, VH
Underlying disease	no	Suspicion of sarcoidosis	no
Medication	CSA 2.1 mg/kg body weight daily	Decortin 0.2 mg/kg body weight once daily	MTX 7.5 mg/m2/once weekly; Prednisolone 0.03 mg/kg body weight once daily
BCVA study eye (ETDRS-letters)	65	55	58
IOP study eye	18	17	18
CDR study eye	0.2	0.2	0.1
Lens status study eye	clear	clear	Subcapsular cataract grade 2+
CRT study eye (μm)	451	320	350
VH study eye	0.5+	1.5+	1.5+
VC study eye	0.5+	0.5+	1+

RA right eye, LE left eye, CME cystoid macular edema, VH vitreous haze, CSA Ciclosporine A, MTX Methotrexate, ETDRS- letters Early Treatment of Diabetic Retinopathy- letters, IOP intraocular pressure, CDR cup/ disc- ratio optic nerve head, CRT central retinal thickness, VC vitreous cells